|
Market Closed -
NYSE
16:00:00 2026-10-15 EDT
|
5-day change | 1st Jan Change | ||
| 42.05 USD | +1.87% |
|
+4.03% | +60.56% |
Main features
| US46435U1925 | Fees | 0.47% | Dividend Policy | Distribution | |
|---|---|---|---|---|---|
| Currency | USD | AuM (CAD) | 342.77M | Replication Method | Direct (Physical) |
| Number of securities | 52 | AuM evolution | - | Date of creation | 2019-06-10 |
NYSEUSD
| Markets | Quality | ||
|---|---|---|---|
CBOE
| IDNA | Real-time | |
NYSE
| IDNA | Delayed |
Easily sort and filter through all available ETFs
Access the ETF ScreenerEconomic news
Investment objective
| Asset Classes | Stocks |
|---|---|
| Geographical Focus | - |
| Theme and Sector | BioTech & Genomics |
The iShares Genomics Immunology and Healthcare ETF seeks to track the investment results of an index composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology, and bioengineering.
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-15 | US$42.05 | +1.87% | 107,612 |
| 26-10-14 | US$41.28 | +1.20% | 291,188 |
| 26-10-13 | US$40.79 | -1.85% | 108,631 |
| 26-10-12 | US$41.56 | -1.45% | 144,354 |
| 26-10-09 | US$42.17 | +4.33% | 151,584 |
- Stock Market
- ETF
- IDNA ETF
Select your edition
All financial news and data tailored to specific country editions




















